On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly ...

Everest Medicines’ Nefecon achieved 167 million yuan in sales in just over a month after its launch, showing its future big ...

A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Researchers are exploring a new mRNA delivery technique to treat genetic conditions in the fetal brain, potentially ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?